Pages that link to "Q36502679"
Jump to navigation
Jump to search
The following pages link to The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target (Q36502679):
Displaying 50 items.
- Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A) (Q24297428) (← links)
- Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells (Q24316354) (← links)
- Emerging preclinical pharmacological targets for Parkinson's disease (Q26764724) (← links)
- GPR109A and vascular inflammation (Q28287747) (← links)
- Nicotinic acid receptor agonists differentially activate downstream effectors (Q28298974) (← links)
- Niacin stimulates adiponectin secretion through the GPR109A receptor (Q28575089) (← links)
- Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists (Q28583868) (← links)
- Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition (Q30414585) (← links)
- The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate (Q31051889) (← links)
- Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3 (Q33789758) (← links)
- Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. (Q33927010) (← links)
- Future of GPR109A agonists in the treatment of dyslipidaemia (Q34171831) (← links)
- Upregulation of GPR109A in Parkinson's disease (Q34361793) (← links)
- Nicotinic acid modulates intracellular calcium concentration and disassembles the cytoskeleton (Q34487985) (← links)
- Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages (Q34565228) (← links)
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells (Q34624990) (← links)
- Nicotinic acid receptor GPR109A is down-regulated in human macrophage-derived foam cells (Q34712851) (← links)
- Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms (Q35025103) (← links)
- Effects of niacin on atherosclerosis and vascular function (Q35132366) (← links)
- High Dietary Niacin May Increase Prostaglandin Formation but Does Not Increase Tumor Formation inApcMin/ Mice (Q35575144) (← links)
- Retinal transfer of nicotinate by H -monocarboxylate transporter at the inner blood-retinal barrier (Q35575652) (← links)
- Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis (Q35608570) (← links)
- The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling (Q35660100) (← links)
- Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice (Q36102106) (← links)
- Familial dyslipidaemias: an overview of genetics, pathophysiology and management (Q36651652) (← links)
- Orphan GPCR research (Q37028758) (← links)
- Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. (Q37097541) (← links)
- Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers (Q37230403) (← links)
- Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia (Q37376937) (← links)
- Novel patent publications on high-affinity nicotinic acid receptor agonists (Q37529810) (← links)
- Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403. (Q37536057) (← links)
- The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. (Q37621301) (← links)
- Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization (Q37635019) (← links)
- Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review (Q37667487) (← links)
- Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation (Q37679063) (← links)
- BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-κB activation (Q37720336) (← links)
- Diagnosis and treatment of severe hypertriglyceridemia (Q37998115) (← links)
- G protein-coupled receptors for energy metabolites as new therapeutic targets (Q38025858) (← links)
- Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81). (Q38351961) (← links)
- Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments. (Q38948892) (← links)
- Constitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells (Q39064720) (← links)
- Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease (Q39132612) (← links)
- Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis (Q39303280) (← links)
- Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia (Q39735403) (← links)
- Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy (Q40154290) (← links)
- Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid (Q41871296) (← links)
- Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions. (Q42168337) (← links)
- Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid (Q42203740) (← links)
- (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans (Q42720311) (← links)
- The role of nicotinic acid metabolites in flushing and hepatotoxicity (Q42752802) (← links)